Tempus AI, Inc. (TEM)
NASDAQ: TEM · Real-Time Price · USD
56.14
+1.27 (2.31%)
At close: Jun 26, 2026, 4:00 PM EDT
55.99
-0.15 (-0.27%)
After-hours: Jun 26, 2026, 7:59 PM EDT
Tempus AI Employees
Tempus AI had 3,800 employees as of December 31, 2025. The number of employees increased by 1,400 or 58.33% compared to the previous year.
Employees
3,800
Change (1Y)
1,400
Growth (1Y)
58.33%
Revenue / Employee
$358,992
Profits / Employee
-$79,713
Market Cap
10.08B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3,800 | 1,400 | 58.33% |
| Dec 31, 2024 | 2,400 | 100 | 4.35% |
| Dec 31, 2023 | 2,300 | 348 | 17.83% |
| Dec 31, 2022 | 1,952 | 385 | 24.57% |
| Dec 31, 2021 | 1,567 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| BrightSpring Health Services | 23,500 |
| Veeva Systems | 7,928 |
| Teladoc Health | 5,600 |
| Omnicell | 3,525 |
| HealthEquity | 2,814 |
| Waystar Holding | 1,700 |
| Privia Health Group | 1,226 |
| 10x Genomics | 1,178 |
TEM News
- 2 days ago - Tempus AI announces research collaboration with Angiosarcoma Awareness - TheFly
- 2 days ago - Tempus Announces Research Collaboration with Angiosarcoma Awareness, Inc. to Uncover Insights on Rare Cancers - Business Wire
- 10 days ago - Tempus AI (TEM) Price Forecast: Consolidation Bottom Breakout Looms - FXEmpire
- 16 days ago - Tempus AI announces publication of multi-center validation of software - TheFly
- 16 days ago - Tempus Announces Multi-Center Validation of AI-Enabled ECG Model for Predicting Atrial Fibrillation Risk Published in Heart Rhythm - Business Wire
- 18 days ago - Genetics in Medicine Open Study Demonstrates How Ambry Genetics' ExomeReveal® RNA Testing Can Improve Diagnostic Clarity in Exome Testing - Business Wire
- 19 days ago - Tempus AI Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 21 days ago - Tempus to Present at the Goldman Sachs 47th Annual Global Healthcare Conference - Business Wire